FDA to Add Warning About Neurological Disorder Linked to Johnson & Johnson COVID-19 Vaccine

By Jack Phillips The U.S. Food and Drug Administration (FDA) on July 12 said it will add a warning label to Johnson & Johnson’s COVID-19 vaccine that it is linked to a rare neurological disorder known as Guillain-Barré syndrome (GBS), while J&J confirmed it is “in discussions” with federal agencies. “The FDA is announcing revisions to the vaccine […]

Enable Notifications    OK No thanks